Xanthigen and Its Impact on Weight and Metabolic Health
In plain words A study of fucoxanthin in people 20 to 50, run by Universidad Católica San Antonio de Murcia. It plans to enroll about 180 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists people 20 to 50; healthy volunteers accepted. Conditions: Obesity & Overweight.
- The subject is able and willing to follow the study protocol procedures to sign the informed consent form prior to the evaluations.
- Participants must be between 20 and 50 years of age at the time of consent.
- The subject is in good physical and mental health as determined by medical history, physical examination, electrocardiogram, vital signs, biochemistry, and hematology results.
- Participants must have a BMI between 27 and 29.9 kg/cm2.
1 more inclusion criterion and the exclusion criteria are on the listing.
What it tests, as registered
Experimental group: Xanthigen®; Control product
Registered summary
Randomized, controlled, triple-blind clinical trial with three parallel arms based on the product consumed (low-dose experimental product, high-dose experimental product, and placebo product) and conducted at a single center to measure the efficacy of a product (Xanthigen®) on overweight or obesity during 16 weeks of consumption.
Where, as registered
No US site; Spain (1).